[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.159.197.114. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Medical News & Perspectives
March 15, 2000

Device Manufacturers Consider Constraints

Author Affiliations
 

Not Available

Not Available

JAMA. 2000;283(11):1410-1411. doi:10.1001/jama.283.11.1410-JMN0315-3-1

Washington—There's no shortage of new ideas and talent devoted to the development and improvement of medical devices for tackling clinical problems. But getting them to patients can be a tedious, highly risky business.

There are uncertainties over financial support. There are difficulties in mounting clinical trials. While the US Food and Drug Administration's (FDA) device regulations have been streamlined recently, there is still room for improvement. And the device industry is plagued by a reimbursement system that is fractionated, unpredictable, and inconsistent.

First Page Preview View Large
First page PDF preview
First page PDF preview
×